Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

January 16, 2022

Role and mechanism(s) of incretin-dependent therapies for treating diabetes mellitus.

Environmental Science and Pollution Research International
Nasr E Nasr, Kadry M Sadek
January 7, 2022

GLP-1 Receptor Agonists as Adjunctive Treatment for Type 1 Diabetes: Renewed Opportunities through Tailored Approaches?

Diabetes, Obesity & Metabolism
Alessandra KobayatiMichael A Tsoukas
January 6, 2022

[Process to insulin for type 2 diabetes mellitus therapy].

Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Franco CosmiDeborah Cosmi
January 6, 2022

Incretins Enhance PGF2α-Induced Synthesis of IL-6 and Osteoprotegerin in Osteoblasts.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
Tomoyuki HiokiHaruhiko Tokuda
December 31, 2021
Case Report
Open Access

Case Report: Off-Label Liraglutide Use in Children With Wolfram Syndrome Type 1: Extensive Characterization of Four Patients.

Frontiers in Pediatrics
Giulio FrontinoLorenzo Piemonti
December 28, 2021
Open Access

NDRG1 Activity in Fat Depots Is Associated With Type 2 Diabetes and Impaired Incretin Profile in Patients With Morbid Obesity.

Frontiers in Endocrinology
Iurii StafeevMarina Shestakova
December 28, 2021

Duodenal mucosal resurfacing with GLP-1 receptor agonism increases postprandial unconjugated bile acid in patients with insulin-dependent type 2 diabetes.

American Journal of Physiology. Endocrinology and Metabolism
Suzanne MeiringJacques J G H M Bergman
December 17, 2021

Liraglutide Treatment Does Not Induce Changes in the Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Diabetic Retinopathy.

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
Thomas Arendt NielsenChristina Brock
December 3, 2021

Antidiabetic effects of quercetin and liraglutide combination through modulation of TXNIP/IRS-1/PI3K pathway.

Cell Biochemistry and Function
Salma M ErakyNada F Abo El-Magd
October 29, 2021

Impact of Albumin-to-Creatinine Ratio Point-of-Care Testing on the Diagnosis and Management of Diabetic Kidney Disease.

Journal of Diabetes Science and Technology
Bernd SchultesGottfried Rudofsky
October 26, 2021

Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia.

Clinical Medicine Insights. Endocrinology and Diabetes
Daria Ja'arahMurtaza M Tambuwala
October 26, 2021

Non-alcoholic fatty liver disease: A patient guideline.

JHEP Reports : Innovation in Hepatology
Sven M FrancqueChristos Lionis
October 8, 2021
Open Access

Alpk1 Sensitizes Pancreatic Beta Cells to Cytokine-Induced Apoptosis via Upregulating TNF-α Signaling Pathway.

Frontiers in Immunology
Fei DingPeilin Zheng
October 8, 2021
Open Access

Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.

Genome Medicine
Karlijn A C MeeksCharles N Rotimi
October 7, 2021

Effects of short-acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes.

Diabetes, Obesity & Metabolism
Nicklas J JohansenFilip K Knop
October 7, 2021

Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin.

Nature Biomedical Engineering
Jung Seok LeeTarek M Fahmy

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

© 2022 Meta ULC. All rights reserved